The pathogenesis of irritable bowel syndrome (IBS) is not yet clear. Our study suggested parasitic infection and other plausible risk factors among Egyptian IBS patients. We studied 40 IBS patients diagnosed according to Rome III criteria (Group I), 40 with other gastrointestinal symptoms (Group II) and 40 healthy controls (Group III). Stool samples were examined using direct wet smear, sedimentation technique, trichrome stain and immune-chromatographic tests for Cryptosporidium parvum. IBS patients displayed a significantly greater percentage of Blastocystis hominis infection (45%) than non-IBS patients (20%) and healthy controls (10%). Dientamoeba fragilis was identified in two IBS patients. Detection of B. hominis was independent of demographic characters, IBS subtype, Helicobacter pylori infection or medications, but with a positive association with a history of antibiotic intake with IBS.
SpiegelBMFaridMEsrailianE, et al.Is irritable bowel syndrome a diagnosis of exclusion?: a survey of primary care providers, gastroenterologists, and IBS experts. Am J Gastroenterol2010; 105: 848–858.
2.
CheyWDKurlanderJEswaranS. Irritable bowel syndrome: a clinical review. JAMA2015; 313: 949–958.
3.
HussainRJaferiWZuberiS, et al.Significantly increased IgG2 subclass antibody levels to Blastocystishominis in patients with irritable bowel syndrome. Am J Trop Med Hyg1997; 56: 301–306.
4.
BorodyTJWarrenEFWettsteinA, et al.Eradication of Dientamoeba fragilis can resolve IBS-like symptoms. J Gastroenterol Hepatol2002; 17(Suppl.): A103–A103.
5.
StewartGT. Post-dysenteric colitis. Br Med J1950; 1: 405–409.
6.
ChaudharyNATrueloveSC. The irritable colon syndrome; a study of the clinical features, predisposing causes and prognosis in 130 cases. Q J Med1962; 31: 307–322.
7.
D’AnchinoMOrlandoDDe FeudisL. Giardia lamblia infections become clinically evident by eliciting symptoms of irritable bowel syndrome. J Infect2002; 45: 169–172.
8.
DrossmanDA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology2006; 130: 1377–1390.
9.
Van den BosscheDCnopsLVerschuerenJ, et al.Comparison of four rapid diagnostic tests, ELISA, microscopy and PCR for the detection of Giardia lamblia, Cryptosporidium spp. and Entamoebahistolytica in feces. J Microbiol Methods2015; 110: 78–84.
10.
AshgarSS. Helicobacter Pylori diagnosis by stool antigen ELISA and rapid test. J Appl Med Sci2013; 2: 61–66.
11.
VillarrealAAAbergerFJBenrudR, et al.Use of broad-spectrum antibiotics and the development of irritable bowel syndrome. WMJ2012; 111: 17–20.
12.
NourrissonCScanziJPereiraB, et al.Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects. PLoS One2014; 9: e111868–e111868.
NealKRHebdenJSpillerR. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ1997; 314: 779–782.
15.
RodriguezLARuigomezA. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ1999; 318: 565–566.
16.
RostamiARiahiSMHaghighiA, et al.The role of Blastocystis sp. and Dientamoebafragilis in irritable bowel syndrome: a systematic review and meta-analysis. Parasitol Res2017; 116: 2361–2371.
17.
TungtrongchitrAManatsathitSKositchaiwatC, et al.Blastocystis hominis infection in irritable bowel syndrome patients. Southeast Asian J Trop Med Public Health2004; 35: 705–710.
18.
LederKHellardMESinclairMI, et al.No correlation between clinical symptoms and Blastocystis hominis in immunocompetent individuals. J Gastroenterol Hepatol2005; 20: 1390–1394.
19.
TanTCSureshKG. Predominance of amoeboid forms of Blastocystis hominis in isolates from symptomatic patients. Parasitol Res2006; 98: 189–193.
20.
AkihoHIharaENakamuraK. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol2010; 1: 97–105.
21.
PoirierPWawrzyniakIVivarèsCP, et al.New insights into Blastocystis spp.: a potential link with irritable bowel syndrome. PLoS Pathog2012; 8: e1002545–e1002545.
22.
HussainRJaferiWZuberiS, et al.Significantly increased IgG2 subclass antibody levels to Blastocystishominis in patients with irritable bowel syndrome. Am J Trop Med Hyg1997; 56: 301–306.
23.
StarkDBeebeNMarriottD, et al.Detection of Dientamoeba fragilis in fresh stool specimens using PCR. Int J Parasitol2005; 35: 57–62.
24.
YakoobJJafriWBegMA, et al.Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria. Parasitol Res2010; 107: 679–684.
